Racial Categories in Medicine: A Failure of Evidence-Based Practice? by Ellison, George T. H et al.
PLoS Medicine  |  www.plosmedicine.org 1434 September 2007  |  Volume 4  |  Issue 9  |  e287
Perspectives
I
n this issue of PLoS Medicine, 
Lundy Braun and colleagues 
from the Race, Medicine, and 
Science Workshop discuss “the trouble 
with race” [1]. They argue that the 
heterogeneity of racial and ethnic 
categories (and a lack of consensus on 
how these categories should be deﬁ  ned 
and measured) make them poor 
markers for underlying differences 
in the genotypic, cultural, and 
structural characteristics responsible 
for inequalities in health (where 
“structural characteristics” include 
a diverse range of historical and 
contemporary socio-political factors 
responsible for differential access 
to health resources and differential 
exposure to health risks). Such racial 
and ethnic categories, they argue, are 
also poor markers for the differential 
efﬁ  cacy of diagnostic and therapeutic 
interventions. 
However, the authors distinguish 
between what they feel to be the 
appropriate descriptive use of such 
categories (to identify differences in 
health and health care that warrant 
further investigation and intervention), 
and their inappropriate attributive use 
(to identify the causal mechanisms 
involved and to select clinical 
interventions). To address the latter, 
they propose substantial improvements 
in international scientiﬁ  c standards 
and clinical training. They suggest 
that these improvements would 
help to prevent biomedical research 
and practice from: (1) reifying the 
discredited notion of races as natural, 
genetically distinct subspecies; and (2) 
treating ethnic groups in stereotypical 
ways as if they were genetically or socio-
culturally homogeneous. 
These seem entirely sensible 
recommendations given that the 
descriptive use of racial and ethnic 
categories to identify differences in 
health and health care can lead to 
the inappropriate attributive use of 
disaggregated ﬁ  ndings in ways that 
misidentify the causal mechanisms 
involved and undermine the impact 
of training in patient-centred care [2]. 
However, while it is crucial to address 
this drift from description to attribution, 
our research on the use of racial and 
ethnic categories in genetics and 
biomedicine suggests that Braun et al.’s 
proposals face a number of intractable 
problems. 
Problems with Deﬁ  nition and 
Standardisation
In particular, we have found that there 
is a lack of consensus about what race 
and ethnicity mean [3] and how these 
should be operationalised [4]. As a 
result, researchers and practitioners 
may conﬂ  ate the utility of racial and 
ethnic categories for sampling diverse 
study populations with their ability 
to identify and address aetiological 
variation therein [5]. At the same 
time, there is widespread concern 
about the socio-political sensitivity of 
such categories and a desire to avoid 
stigmatising populations and groups 
found to be at greater risk of disease 
[6]. This concern has led many of 
the researchers we interviewed to 
adopt the more socially acceptable 
term “ethnicity” in preference to 
“race” [6]. It has also led some 
researchers to use crude socio-political 
classiﬁ  cations (such as the categories 
developed by the United States Ofﬁ  ce 
of Management and Budget [OMB] 
and by the United Kingdom Ofﬁ  ce for 
National Statistics [ONS]) not only 
for sampling diverse study populations 
and describing population differences 
in health and health care, but also for 
attributing these differences to innate 
genotypic and/or socio-cultural causes 
[4]. 
Thus, even though the researchers 
themselves often recognise that racial 
and ethnic categories are imprecise 
markers of genotypic and socio-cultural 
determinants of variation in health 
[5], they have adopted an essentially 
pragmatic response to the perceived 
need for standardised, salient, and 
politically sensitive classiﬁ  cations [4]. 
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Linked Essay
This Perspective discusses the 
following new Essay published in PLoS 
Medicine:
Braun L, Fausto-Sterling A, Fullwiley 
D, Hammonds EM, Nelson A, et al. (2007) 
Racial categories in medical practice: 
How useful are they? PLoS Med 4(9): 
e271. doi:10.1371/journal.pmed.0040271
In this Essay, the authors address the 
question of whether it is good medical 
practice for physicians to “eyeball” a 
patient’s race when assessing their 
medical status.PLoS Medicine  |  www.plosmedicine.org 1435 September 2007  |  Volume 4  |  Issue 9  |  e287
Some justify this response on the 
grounds that however crude racial 
and ethnic categories might be, they 
can nonetheless successfully describe 
differences between populations 
that are biomedically relevant [6]. 
Others argue that using crude generic 
socio-political classiﬁ  cations of race 
and ethnicity (as opposed to more 
precise bespoke scientiﬁ  c categories) 
helps facilitate the “portability” and 
“translation” of ﬁ  ndings both within 
the biomedical research community 
itself, and between researchers, 
clinicians, and policy makers [4]. 
National Mandates to Describe 
Race and Ethnicity 
The use of crude socio-political 
categories of race and ethnicity to 
describe variation in health risks and 
health needs, and to attribute these 
differences to innate genotypic and 
socio-cultural factors, has a long and 
discredited history, as Braun and 
colleagues describe [1]. However, 
more recently this practice seems to 
have been resurrected and validated, 
however unwittingly, by the adoption of 
such categories to promote equitable 
participation of “minorities” in research 
and to ensure that researchers are able 
to identify and describe any differences 
between racial and ethnic groups 
that warrant further investigation and 
intervention [7]. 
Certainly, some of the US-based 
researchers we interviewed cited the 
adoption of the OMB categories by 
the United States National Institutes 
of Health (NIH) to justify their use of 
such categories in their research [6]. 
In the UK, the Department of Health 
(DH) has mandated the classiﬁ  cation 
of all National Health Service patients 
using the ONS categories since 1995 
[8]. Although there is currently no 
requirement for UK-based biomedical 
scientists to use these categories in their 
research, we have found that many 
have adopted the ONS categories in 
their sampling strategies and analytical 
designs [4]. Indeed, it seems likely that 
more researchers will follow suit in 
response to a 2001 directive from the 
DH which charges researchers to ensure 
that “the body of research evidence 
available to policy makers reﬂ  ects the 
diversity of the population” [9] and 
requires research ethics committees to 
scrutinise the diversity of proposed study 
populations along these lines [10]. 
In this way, policies that use crude 
socio-political categories of race 
and ethnicity to promote equitable 
participation in biomedical research, 
and to provide descriptive evidence of 
variation in health risks and health 
needs that warrant further investigation 
and intervention, run the risk of 
undermining moves to generate the 
more precise attributive evidence 
required to improve the equitable 
delivery of health care. This is because, 
despite growing consensus about 
the imprecision of racial and ethnic 
categories as markers for genotypic and 
socio-cultural determinants of health, 
the use of these categories to promote 
equitable participation in biomedical 
research and to describe variation in 
health risk leads to the use of the 
same crude categories to (mis)attribute 
causality and thereby (mis)identify 
health care needs. 
Toward the Use of Context-Speciﬁ  c 
Attributive Markers
The attributive use of crude socio-
political categories of race and 
ethnicity in biomedical research and 
practice is not, however, an inevitable 
consequence of policies to promote 
equitable inclusion in research or to 
describe disparities in health and health 
care that warrant further investigation 
and intervention. Researchers are not 
required to limit the variables they 
use to explore disparities in health, 
and clinicians are not obliged to use 
crude racial and ethnic categories 
to select the care they provide. But 
researchers and clinicians do need to 
be encouraged to use more speciﬁ  c 
attributive markers of genotype, culture, 
and structural disadvantage wherever 
appropriate. 
For example, in transplantation 
research, the polymorphic genotypes 
that determine histocompatibility 
antigens (HLAs) and inﬂ  uence the 
success of organ transplants are 
known to vary in frequency amongst 
different racial and ethnic groups 
[11]. These genotypic differences 
have often been cited to explain racial 
and ethnic variation in morbidity and 
mortality amongst patients requiring 
organ transplantation [12]. Yet 
these genotypic differences cannot 
explain differential access to organ 
transplantation nor the differential 
efﬁ  cacy of transplantation practices. 
Instead, we need to examine the 
differential impact of cultural and 
structural factors that inﬂ  uence the 
availability of suitable organs [11], 
and of clinical policies that prioritise 
the transplantation of organs to HLA-
matched recipients rather than to 
recipients at greatest clinical need [13]. 
Thus, crude socio-political categories 
of race and ethnicity are only useful as 
descriptive markers of the potential for 
racial/ethnic discrimination and of 
related structural factors that inﬂ  uence 
exposure to health risks, access to 
health care, and inclusion in health 
research. And even their apparent 
utility for this speciﬁ  c purpose is 
likely to be undermined by the ﬂ  uid 
and context-speciﬁ  c nature of racial 
and ethnic identities, which resist 
standardisation for use in different 
scientiﬁ  c, social, and clinical contexts. 
Indeed, attempts to standardise racial 
and ethnic categories for use across 
different national settings have met 
with little success. Such attempts have 
concluded that it may only be possible 
to use context-speciﬁ  c categories to 
assess discrimination and related 
structural factors associated with 
each setting’s particular history and 
contemporary experience of racial and 
ethnic identities [14]. 
A Role for the United States 
National Institutes of Health and 
World Health Organization?
So while we would support Braun 
and colleagues’ call for international 
consensus to improve the use of racial 
and ethnic categories in biomedical 
research and practice [1], such 
categories cannot and should not be 
standardised for use in all scientiﬁ  c, 
social, and clinical contexts, even if 
only for use as descriptive variables. 
Instead, we need to recognise that 
different racial and ethnic categories 
are needed to describe inequalities 
in health and health care in contexts 
where these have different salience and 
meaning. At the same time, alternative 
attributive markers of genotypic, 
cultural, and structural determinants 
of variation in health and access to 
health care need to be developed in 
order to: (1) improve the aetiological 
precision of biomedical research; 
and (2) facilitate the translation of 
research on the causes of variation in 
health across racial and ethnic groups 
into appropriate care for individual 
patients. This more precise approach PLoS Medicine  |  www.plosmedicine.org 1436 September 2007  |  Volume 4  |  Issue 9  |  e287
would help to address a long-standing 
problem with evidence-based practice, 
which often struggles to apply the 
results of epidemiological research 
on populations to the clinical care of 
individuals [15]. 
Certainly, the NIH concedes 
that “The scientiﬁ  c question being 
addressed in the study should guide 
investigators’ decisions regarding 
collection of any additional 
information on ethnicity and race” 
[16]. However, our proposal for the use 
of different racial and ethnic categories 
as descriptive variables in different 
scientiﬁ  c, clinical, and social contexts, 
and for more precise genotypic, 
cultural, and structural variables to 
attribute the causes of racial and ethnic 
inequalities in health and health care, 
faces a number of difﬁ  cult challenges. 
These include a lack of consensus on 
whether, and how, race and ethnicity 
should be operationalised in different 
scientiﬁ  c, clinical, and social contexts 
[3,4,14,17], and the need to develop 
standard instruments for capturing 
genotypic, cultural, and structural 
characteristics amenable for use across 
these contexts. It is also unclear who 
might be best placed to promote 
such consensus or develop such 
instruments. Funding agencies and 
those generating practice guidelines, 
such as the NIH and the World Health 
Organization, have a potential role to 
play (as Braun and colleagues suggest 
[1]). But these bodies cannot enforce 
guidelines for research sponsored 
by other funders nor guidelines for 
practice implemented by other health 
care providers. This would require 
unprecedented agreement amongst 
a comprehensive international 
consortium of funders and providers. 
A Role for Biomedical Journals?
An alternative approach would be to 
target the gatekeepers of research 
dissemination, particularly the editors 
of biomedical journals, who have 
displayed increasing willingness to 
improve the use of racial and ethnic 
categories in published research [18]. 
Certainly, our research has identiﬁ  ed 
many journals that have generated 
a range of dedicated guidelines for 
authors [4,17], even if many biomedical 
journals simply encourage authors 
to “justify” the categories they use. 
These include, for example, the 648 
journals signed up to the International 
Committee of Medical Journal Editors’ 
Uniform Requirements for Manuscripts 
Submitted to Biomedical Journals: Writing 
and Editing for Biomedical Publication, 
which recommend that “When authors 
use variables such as race or ethnicity, 
they should deﬁ  ne how they measured 
the variables and justify their relevance” 
[19].
However, we have also found that 
many editors are unwilling to generate 
and impose guidelines without the 
support of the scientiﬁ  c communities 
they serve [6], and that even when 
detailed guidelines have been 
produced these have had little impact 
on the content of the articles they 
publish [20]. International consensus 
amongst biomedical researchers and 
practitioners is therefore required to 
support editors in the development and 
application of guidelines for:
1. improving the use of context-
speciﬁ  c racial and ethnic categories 
as descriptive markers of inequalities in 
health and health care; 
2. promoting the use of more precise 
and portable attributive markers of 
the genotypic, cultural, and structural 
determinants of racial and ethnic 
inequalities in health and health care; 
and thereby 
3. generating evidence from 
population studies of racial and ethnic 
groups that can be used to improve 
the care of individual patients from 
these groups across different social and 
clinical contexts.  
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